Celiac Disease and Autoimmune Diseases in a Pediatric Population in Morocco: A Cross-Sectional Study

Hanane Hajaj1, Aziza Elouali1, Amal Hamami1

  • 1Department of Pediatrics, University Hospital Mohammed VI, Faculty of Medicine and Pharmacy, Mother and Child Health Laboratory, Mohammed First University, Oujda, MAR.

Cureus
|July 2, 2024
PubMed

Insights

Celiac disease (CD) patients under 16 have a higher risk of autoimmune diseases (AD), particularly type 1 diabetes and autoimmune thyroiditis. Early detection and management are crucial for better outcomes in pediatric CD patients with associated AD.

Area of Science:

  • Pediatric Gastroenterology
  • Autoimmunology
  • Clinical Research

Background:

  • Celiac disease (CD) is an autoimmune disorder triggered by gluten in genetically susceptible individuals.
  • Previous studies indicate an elevated risk of autoimmune diseases (AD) in CD patients.
  • This study systematically investigates AD prevalence in pediatric CD patients.

Purpose of the Study:

  • To determine the prevalence of AD in children diagnosed with CD.
  • To identify potential risk factors associated with the development of AD in this cohort.
  • To inform clinical practice regarding surveillance and management.

Main Methods:

  • Retrospective analysis of medical data from 60 pediatric CD patients (under 16 years).
  • Data collected from January 2017 to January 2024 at Mohamed VI Hospital and University Center, Oujda, Morocco.
  • Focus on patients diagnosed with both CD and AD.

Main Results:

  • Eight out of 60 pediatric CD patients (13%) presented with an associated AD.
  • The average age of affected children was 8 years (range 2-15 years).
  • AD was diagnosed prior to CD in 75% of cases, with type 1 diabetes being the most common (7 cases) followed by autoimmune thyroiditis (1 case).

Conclusions:

  • Pediatric CD patients exhibit an increased susceptibility to autoimmune diseases, notably type 1 diabetes and hypothyroidism.
  • Enhanced surveillance is essential for early diagnosis of these associated conditions.
  • Timely management can mitigate long-term complications in children with CD and co-existing AD.
Abstract